These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


325 related items for PubMed ID: 15583264

  • 41. Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.
    Williams MM, Sen K, Weigand MR, Skoff TH, Cunningham VA, Halse TA, Tondella ML, CDC Pertussis Working Group.
    Emerg Infect Dis; 2016 Feb; 22(2):319-322. PubMed ID: 26812174
    [Abstract] [Full Text] [Related]

  • 42. [Modern strains of Bordetella pertussis: immunobiological properties and vaccine improvement].
    Shinkarev AS, Mertsalova NU, Mazurova IK, Borisova OIu, Zakharova NS, Ozeretskovskaia MN, Zaĭtsev EM, Poddubikov AV, Britsina MV, Bazhanova IG.
    Zh Mikrobiol Epidemiol Immunobiol; 2007 Feb; (4):20-5. PubMed ID: 17886371
    [Abstract] [Full Text] [Related]

  • 43. Genome characteristics of Bordetella pertussis isolates from Tunisia.
    Ben Fraj I, Bouchez V, Smaoui H, Kechrid A, Brisse S.
    J Med Microbiol; 2019 Sep; 68(9):1320-1323. PubMed ID: 31329091
    [Abstract] [Full Text] [Related]

  • 44. Small mutations in Bordetella pertussis are associated with selective sweeps.
    van Gent M, Bart MJ, van der Heide HG, Heuvelman KJ, Mooi FR.
    PLoS One; 2012 Sep; 7(9):e46407. PubMed ID: 23029513
    [Abstract] [Full Text] [Related]

  • 45. Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004.
    Advani A, Donnelly D, Gustafsson L, Hallander HO.
    APMIS; 2007 Apr; 115(4):299-310. PubMed ID: 17504296
    [Abstract] [Full Text] [Related]

  • 46. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.
    Buasri W, Impoolsup A, Boonchird C, Luengchaichawange A, Prompiboon P, Petre J, Panbangred W.
    BMC Microbiol; 2012 Apr 23; 12():61. PubMed ID: 22524455
    [Abstract] [Full Text] [Related]

  • 47. Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model.
    Komatsu E, Yamaguchi F, Abe A, Weiss AA, Watanabe M.
    Clin Vaccine Immunol; 2010 May 23; 17(5):807-12. PubMed ID: 20357056
    [Abstract] [Full Text] [Related]

  • 48. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.
    Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ.
    Infect Immun; 1998 Feb 23; 66(2):670-5. PubMed ID: 9453625
    [Abstract] [Full Text] [Related]

  • 49. Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015.
    Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S, Stefanelli P, van Gent M, Berbers G, Vestrheim D, Greve-Isdahl M, Wehlin L, Ljungman M, Fry NK, Markey K, He Q.
    Euro Surveill; 2019 Feb 23; 24(7):. PubMed ID: 30782265
    [Abstract] [Full Text] [Related]

  • 50. Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains.
    Kourova N, Caro V, Weber C, Thiberge S, Chuprinina R, Tseneva G, Guiso N.
    J Clin Microbiol; 2003 Aug 23; 41(8):3706-11. PubMed ID: 12904379
    [Abstract] [Full Text] [Related]

  • 51. Studies on Prn variation in the mouse model and comparison with epidemiological data.
    van Gent M, van Loo IH, Heuvelman KJ, de Neeling AJ, Teunis P, Mooi FR.
    PLoS One; 2011 Mar 25; 6(3):e18014. PubMed ID: 21464955
    [Abstract] [Full Text] [Related]

  • 52. Pertussis Resurgence Associated with Pertactin-Deficient and Genetically Divergent Bordetella Pertussis Isolates in Israel.
    Bamberger E, Abu Raya B, Cohen L, Golan-Shany O, Davidson S, Geffen Y, Srugo I.
    Pediatr Infect Dis J; 2015 Aug 25; 34(8):898-900. PubMed ID: 25966915
    [Abstract] [Full Text] [Related]

  • 53. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
    Xu Z, Octavia S, Luu LDW, Payne M, Timms V, Tay CY, Keil AD, Sintchenko V, Guiso N, Lan R.
    Emerg Infect Dis; 2019 Jun 25; 25(6):1196-1199. PubMed ID: 31107218
    [Abstract] [Full Text] [Related]

  • 54. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.
    Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N.
    Vaccine; 2009 Oct 09; 27(43):6034-41. PubMed ID: 19666155
    [Abstract] [Full Text] [Related]

  • 55. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.
    Otsuka N, Han HJ, Toyoizumi-Ajisaka H, Nakamura Y, Arakawa Y, Shibayama K, Kamachi K.
    PLoS One; 2012 Oct 09; 7(2):e31985. PubMed ID: 22348138
    [Abstract] [Full Text] [Related]

  • 56. Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986-2015.
    Mir-Cros A, Moreno-Mingorance A, Martín-Gómez MT, Codina G, Cornejo-Sánchez T, Rajadell M, Van Esso D, Rodrigo C, Campins M, Jané M, Pumarola T, Fàbrega A, González-López JJ.
    Emerg Microbes Infect; 2019 Oct 09; 8(1):1711-1720. PubMed ID: 31769735
    [Abstract] [Full Text] [Related]

  • 57. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
    Martin SW, Pawloski L, Williams M, Weening K, DeBolt C, Qin X, Reynolds L, Kenyon C, Giambrone G, Kudish K, Miller L, Selvage D, Lee A, Skoff TH, Kamiya H, Cassiday PK, Tondella ML, Clark TA.
    Clin Infect Dis; 2015 Jan 15; 60(2):223-7. PubMed ID: 25301209
    [Abstract] [Full Text] [Related]

  • 58. The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis.
    Clarke M, McIntyre PB, Blyth CC, Wood N, Octavia S, Sintchenko V, Giles L, Quinn H, Hill V, Hanly G, Lan R, Marshall HS.
    J Infect; 2016 Feb 15; 72(2):171-8. PubMed ID: 26675318
    [Abstract] [Full Text] [Related]

  • 59. Comparative genomics of whole-cell pertussis vaccine strains from India.
    Alai S, Ghattargi VC, Gautam M, Patel K, Pawar SP, Dhotre DP, Shaligram U, Gairola S.
    BMC Genomics; 2020 May 07; 21(1):345. PubMed ID: 32381023
    [Abstract] [Full Text] [Related]

  • 60. Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959-2013.
    Mosiej E, Zawadka M, Krysztopa-Grzybowska K, Polak M, Augustynowicz E, Piekarska K, Lutyńska A.
    Eur J Clin Microbiol Infect Dis; 2015 Jan 07; 34(1):147-152. PubMed ID: 25090968
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.